John Demaree is Chief Commercial Officer of G1 Therapeutics. Previously, he served as Vice President, Oncology marketing for Astellas where he led several product launches. He has worked for more than 20 years in oncology including roles of increasing leadership at Eli Lilly, Novartis and Abbott. Mr. Demaree brings to G1 a strong history of building commercial capabilities and leading multiple successful new product and new indication launches. His areas of expertise include strategy, commercialization, new product launches, market access and reimbursement strategy, internal and external collaboration leadership, and business development and licensing. Mr. Demaree received his BS in Marketing and his MBA in Marketing and Finance from Indiana University.